Tips for creating the best market access and reimbursement strategy for your medical device

Launching a new medical device requires careful development of your market access and reimbursement strategy. This process can take between five and seven years, so it’s important to have this strategy locked in before FDA submission. Knowing how critical this process is to achieving success, we’re hosting a webinar to talk through everything market access and HEOR in medical device companies. Mary Nojeim, Senior Data Analysis Manager of Definitive Healthcare and Robert Bargenquast, Head of U.S. Market Access Strategy and Reimbursement at Carl Zeiss Meditech Inc., share the important actions you should consider when preparing for a new launch.